IC
ACET icon

Ikarian Capital’s Adicet Bio ACET Stock Holding History

Ikarian Capital’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,951
Closed -$2.09M – 104
2022
Q2 		$2.09M Sell
8,951
-22,758
-72% -$5M 0.38% 56
2022
Q1 		$10.1M Buy
31,709
+1,870
+6% +$430K 1.33% 22
2021
Q4 		$8.35M Buy
29,839
+5,313
+22% +$912K 1.24% 22
2021
Q3 		$3.08M Buy
24,526
+16,679
+213% +$2.07M 0.22% 106
2021
Q2 		$1.29M Sell
7,847
-596
-7% -$121K 0.1% 151
2021
Q1 		$1.77M Sell
8,443
-2,449
-22% -$562K 0.06% 210
2020
Q4 		$2.45M Sell
10,892
-6,250
-36% -$1.28M 0.11% 143
2020
Q3 		$3.26M Buy
17,142
+4,173
+32% +$1.06M 0.24% 88
2020
Q2 		$3.12M Buy
+12,969
New +$2.55M 0.25% 89

Other funds holding ACET

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Ikarian Capital's ACET Position: Q3 2022 in Review

Ikarian Capital sold out of Adicet Bio (ACET) in Q3 2022, closing a stake of 8,951 shares — an estimated $2.09M sold.

Ikarian Capital first reported a position in ACET in Q2 2020 and held it in 9 quarters. The position peaked at $10.1M in Q1 2022. 102 funds tracked by Wall St. Rank hold ACET as of Q3 2022.

  • Ikarian Capital reported no remaining Adicet Bio position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 8,951 Adicet Bio shares in Q3 2022, an estimated $2.09M.
  • Ikarian Capital first reported a position in Adicet Bio in Q2 2020 and held it in 9 quarters.
  • Ikarian Capital's Adicet Bio position peaked at $10.1M in Q1 2022.
  • 102 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.